Foghorn Therapeutics Inc (FHTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $124.12M
Last updated: Nov 17, 2026 at 4:26 PM ET
Foghorn Therapeutics Inc (FHTX) Stock Chart
Foghorn Therapeutics (FHTX) has a latest price of $1.83 on Nov 17, 2026, 76.0% below its 52-week high of $7.61. Its price fell 61.0% over the past 12 months. The month-end price fell 83.6% over the 5 years through Oct 2026, a compound annual decline of 30.4%.
Price Chart
From Oct 2020 to Oct 2026, its highest month-end close was $22.87 in Dec 2021 and its lowest $2.08 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart FHTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FHTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 74.1%, and over 6 months it fell 49.2%. The month-end price fell 37.9% over the 3 years through Oct 2026, a compound annual decline of 14.7%.
| Period | Change |
|---|---|
| 1 month | -2.1% |
| 3 months | -74.1% |
| 6 months | -49.2% |
| 12 months | -61.0% |
| 12 months, with dividends | -61.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -37.9% | -14.7% |
| 5 years | -83.6% | -30.4% |
Price by Year
Its best calendar year was 2025, when the price rose 14.4%, and its weakest was 2022, when it fell 72.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.08 | -61.5% |
| 2025 | $5.40 | +14.4% |
| 2024 | $4.72 | -26.8% |
| 2023 | $6.45 | +1.1% |
| 2022 | $6.38 | -72.1% |
| 2021 | $22.87 | +12.8% |
Trading Range
The price is 31.3% below its 50-day average of $2.66 and 59.1% below its 200-day average of $4.47.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.83 | |
| 52-week high | $7.61 | -76.0% |
| 52-week low | $1.76 | +3.7% |
| 50-day average | $2.66 | -31.3% |
| 200-day average | $4.47 | -59.1% |
Price Risk
Over 3 years, its largest fall from a peak was 82.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.75 |
| Largest fall, 1 year | -74.7% |
| Largest fall, 3 years | -82.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About FHTX
What is FHTX's 1-year price change?
Foghorn Therapeutics's price fell 61.0% over the past 12 months. With dividends included, the 12-month total return was -61.0%.
What is FHTX's 5-year price change?
Foghorn Therapeutics's month-end price fell 83.6% over the 5 years through Oct 2026, a compound annual decline of 30.4%. These figures leave out dividends.
What is FHTX's 52-week high and low?
Foghorn Therapeutics's 52-week high is $7.61 and its 52-week low is $1.76. Its latest price of $1.83 on Nov 17, 2026 is 76.0% below the high.
What is FHTX's beta?
Foghorn Therapeutics's 1-year beta against the S&P 500 is 1.75, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 74.7%.
Is the FHTX chart free?
Yes. Advanced Charting for FHTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
FHTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors